Decrease of skin reactivity to histamine in lung cancer patients

E. Passowicz-Muszynska (Wroclaw, Poland)

Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Session: Various diagnostic aspects in lung cancer and rare lung tumours
Session type: Thematic Poster Session
Number: 2710

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Passowicz-Muszynska (Wroclaw, Poland). Decrease of skin reactivity to histamine in lung cancer patients. Eur Respir J 2009; 34: Suppl. 53, 2710

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increase of skin reactivity to histamine after chemotherapy in patients with lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Skin reactivity to histamine and expression of histamine receptors mRNA in lymphocytes in lung cancer patients and healthy subjects
Source: Eur Respir J 2003; 22: Suppl. 45, 257s
Year: 2003

Comparison of skin reactivity to histamine in atopic and cancer patients
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

Tumor markers in bronchial secretions and serum in patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 76s
Year: 2004

Cough receptor sensitivity to capsaicin in patients with lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 104s
Year: 2001

The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

Histamine receptors in lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 812s
Year: 2006

Expression of MAGE in the induced sputum of lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 595s
Year: 2002

Decreased reactivity of the alveolar macrophages in relation to ICAM-1 expression after IFNγ stimulation in lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 276s
Year: 2002

Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Elevated endogenous thrombin potential in patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 199s
Year: 2003

Influence of the lung resection to small airways function in patients with limited and normal lung function and primary non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 718s
Year: 2006

Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


The lung microcirculation changes in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 407s
Year: 2006

Changes in lung function tests in lung carcinoma patients due to radiotherapy
Source: Eur Respir J 2001; 18: Suppl. 33, 221s
Year: 2001

Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008


Changes in the pulmonary microbiome associated with lung cancer
Source: International Congress 2019 – Biology of lung cancer
Year: 2019


Decreasing of lung function in patients with chronically obstructive lung diseases as effect of damage of bronchial mucosa cilia
Source: Eur Respir J 2003; 22: Suppl. 45, 416s
Year: 2003

Retinoid Receptors levels in normal bronchial mucosa and in lung cancer cell lines
Source: Eur Respir J 2003; 22: Suppl. 45, 225s
Year: 2003

Systemic inflamation and bronchial dysplasia in risk lung cancer subjects
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009